WO2024218682 - SOLID STATE FORMS OF FOSGONIMETON AND SALTS THEREOF
National phase entry:
Publication Number
WO/2024/218682
Publication Date
24.10.2024
International Application No.
PCT/IB2024/053749
International Filing Date
17.04.2024
Title **
[English]
SOLID STATE FORMS OF FOSGONIMETON AND SALTS THEREOF
[French]
FORMES À L'ÉTAT SOLIDE DE FOSGONIMETON ET LEURS SELS
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
124 Dvora HaNevi'a St.
6944020 Tel Aviv, IL
Inventors
LANDEKA, Ivana
Radoslava Cimermana 56A
10000 Zagreb, HR
KARADAKIĆ, Klara
Dubečka ulica 8a
10 360 Sesvete, HR
ŠKALEC ŠAMEC, Dijana
Malunje 5
10450 Jastrebarsko, HR
Priority Data
63/460,073
18.04.2023
US
63/472,857
14.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2089 | |
| EPO | Filing, Examination | 12421 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 10710 |
Total: 26422 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure encompasses solid state forms of Fosgonimeton and salts thereof, and pharmaceutical compositions thereof.[French]
La présente divulgation concerne des formes à l'état solide de Fosgonimeton et de sels de celui-ci, ainsi que des compositions pharmaceutiques de ceux-ci.